Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    pomalidomide | Open Studies | multiple myeloma | Phase 2
Show Display Options
Rank Status Study
1 Recruiting Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma in Relapse;   Multiple Myeloma, Refractory
Interventions: Drug: Pomalidomide;   Drug: Cyclophosphamide;   Drug: Dexamethasone
2 Recruiting A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
Conditions: Multiple Myeloma;   First Relapse
Interventions: Drug: PCD;   Procedure: Autologous transplantation (ASCT)
3 Recruiting Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Ibrutinib;   Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: Placebo
4 Recruiting Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients
Condition: Multiple Myeloma
Intervention: Drug: Filanesib, pomalidomide and dexamethasone
5 Recruiting Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Condition: Multiple Myeloma
Interventions: Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: Daratumumab
6 Recruiting A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Elotuzumab;   Drug: Pomalidomide;   Drug: Bortezomib;   Drug: Dexamethasone
7 Recruiting Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)
Condition: Multiple Myeloma
Interventions: Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: Cyclophosphamide
8 Recruiting Study of Pomalidomide and Dexamethasone With Growth Factor Support in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: G-CSF;   Behavioral: Phone Calls
9 Recruiting Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: MK-3475;   Drug: Pomalidomide;   Drug: Dexamethasone
10 Recruiting Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Refractory Multiple Myeloma
Condition: Multiple Myeloma in Relapse
Interventions: Drug: pomalidomide;   Drug: ixazomib;   Drug: dexamethasone
11 Recruiting Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: pomalidomide;   Drug: carfilzomib;   Drug: dexamethasone
12 Recruiting Selinexor and Backbone Treatments of Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Selinexor;   Drug: Dexamethasone;   Drug: Lenalidomide;   Drug: Pomalidomide;   Drug: Bortezomib
13 Recruiting A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib;   Drug: Pomalidomide;   Drug: Dexamethasone
14 Recruiting Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Romidepsin;   Drug: pomalidomide;   Drug: Dexamethasone
15 Recruiting Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)
Condition: Multiple Myeloma
Interventions: Drug: Elotuzumab;   Drug: Pomalidomide;   Drug: Dexamethasone
16 Recruiting SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: SL-401/ Pomalidomide/ Dexamethasone
17 Recruiting A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: MOR03087 phase 1 dose escalation;   Drug: MOR03087;   Drug: Dexamethasone;   Drug: Pomalidomide;   Drug: Lenalidomide
18 Unknown  Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Condition: Multiple Myeloma
Interventions: Drug: dexamethasone;   Drug: clarithromycin;   Drug: Pomalidomide
19 Recruiting Pomalidomide for Lenalidomide for Failures
Condition: Multiple Myeloma
Interventions: Drug: POM;   Drug: Steroids;   Drug: PLD;   Drug: CFZ;   Drug: BTZ;   Drug: CLA;   Drug: Other drugs
20 Recruiting Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Clarithromycin;   Drug: Dexamethasone;   Drug: Ixazomib Citrate;   Drug: Pomalidomide

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years